Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Glucagon-like peptide-1 agonists (GLP-1RA, GLP-1DAs, incretin mimetics, or GLP-1 analogs) represent a category of therapeutics used in the treatment of type 2 diabetes mellitus (T2DM) and obesity
Excess body fat, particularly around the abdomen, can lead to insulin resistance and inflammation, both of which contribute to the development of diabetes
This perspective allows a more coherent understanding of how lifestyle and nutritional interventions may preserve circadian integrity and promote healthy aging
Glucagon antagonist activity in the liver can help manage hyperglyciemia in diabetes patients by inhibiting glucogenesis and normalizing blood sugar levels
US$ 24.00
US$ 21.40
US$ 22.17
US$ 22.72
US$ 29.13
US$ 26.22
US$ 24.42
US$ 23.40
